NP mentioned reducing fibrosis in trials. Whether
Post# of 148302
(Total Views: 421)
Posted On: 12/20/2019 7:23:59 AM
Re: generactor #13372
NP mentioned reducing fibrosis in trials. Whether he was talking about Cytodyn's preclinical trials or maraviroc's trials. I believe leronlimab's effect on inflammation is greater than maraviroc so our results should be superior.
maraviroc studies -
https://www.ncbi.nlm.nih.gov/pubmed/25394147?dopt=Abstract
maraviroc studies -
https://www.ncbi.nlm.nih.gov/pubmed/25394147?dopt=Abstract
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼